Characterization of a new muscarinic receptor antagonist PNU-171990 in guinea pig, cat and human smooth muscle
Ali‐Reza Modiri(Uppsala University), Per‐Göran Gillberg(Uppsala University), Pēteris Alberts(Maxygen (United States)), Mervi Vasänge(AstraZeneca (Sweden)), Staffan Sundquist, S. S. Jossan
Cited by 2
Related Papers
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains
|Endocrinology|2003|263
Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice
|Diabetologia|2002|259
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1
|Journal of Medicinal Chemistry|2002|211
The advent of oncolytic virotherapy in oncology: The Rigvir® story
|European Journal of Pharmacology|2018|179